From a diagnostic perspective, one of the key goals in establishing diagnostic criteria is to aid in distinguishing between the two broad pathological categories that underpin non-semantic PPA: FTLD (comprising tau and TDP-43 pathology) and AD. This evidence concerns the gene TARDBP and Alzheimer disease.